BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3479414)

  • 1. Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification.
    Shimosaka A; Kawai H; Hayakawa Y; Komeshima N; Nakagawa M; Seto H; Otake N
    J Antibiot (Tokyo); 1987 Sep; 40(9):1283-91. PubMed ID: 3479414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arugomycin, a new anthracycline antibiotic. I. Taxonomy, fermentation, isolation and physico-chemical properties.
    Kawai H; Hayakawa Y; Nakagawa M; Furihata K; Furihata K; Shimazu A; Seto H; Otake N
    J Antibiot (Tokyo); 1987 Sep; 40(9):1266-72. PubMed ID: 3479412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arugomycin, a new anthracycline antibiotic.
    Kawai H; Hayakawa Y; Nakagawa M; Imamura K; Tanabe K; Shimazu A; Seto H; Otake N
    J Antibiot (Tokyo); 1983 Nov; 36(11):1569-71. PubMed ID: 6651934
    [No Abstract]   [Full Text] [Related]  

  • 4. Arugomycin, a new anthracycline antibiotic. II. Structural elucidation.
    Kawai H; Hayakawa Y; Nakagawa M; Furihata K; Seto H; Otake N
    J Antibiot (Tokyo); 1987 Sep; 40(9):1273-82. PubMed ID: 3479413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthracycline antibiotics, auramycins and sulfurmycins. II. Isolation and characterization of 10 minor components (C approximately G).
    Hoshino T; Tazoe M; Nomura S; Fujiwara A
    J Antibiot (Tokyo); 1982 Oct; 35(10):1271-9. PubMed ID: 7186414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and biological activity of marcellomycin, an antitumor anthracycline antibiotic, and taxonomy of the producing organism.
    Bush JA; Bradner WT; Tomita K
    J Antibiot (Tokyo); 1982 Sep; 35(9):1174-83. PubMed ID: 6754675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on a novel antitumor antibiotic, phenazinomycin: taxonomy, fermentation, isolation, and physicochemical and biological characteristics.
    Omura S; Eda S; Funayama S; Komiyama K; Takahashi Y; Woodruff HB
    J Antibiot (Tokyo); 1989 Jul; 42(7):1037-42. PubMed ID: 2753810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viriplanin A, a new anthracycline antibiotic of the nogalamycin group. I. Isolation, characterization, degradation reactions and biological properties.
    Hütter K; Baader E; Frobel K; Zeeck A; Bauer K; Gau W; Kurz J; Schröder T; Wünsche C; Karl W
    J Antibiot (Tokyo); 1986 Sep; 39(9):1193-204. PubMed ID: 3023268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New anthracycline antibiotics taurimycins A and B produced by a Str. tauricus No. 7036-1 culture].
    Frolova VI; Kuzovkov AD; Rozynov BV; Taĭg MM; Ivanitskaia LP
    Antibiotiki; 1982 May; 27(5):326-31. PubMed ID: 6954874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antitumor antibiotic, kazusamycin.
    Umezawa I; Komiyama K; Oka H; Okada K; Tomisaka S; Miyano T; Takano S
    J Antibiot (Tokyo); 1984 Jul; 37(7):706-11. PubMed ID: 6432763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.
    Skovsgaard T; Danø K; Nissen NI
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():63-72. PubMed ID: 6375864
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on tomaymycin. III. Synthesis and antitumor activity of tomaymycin analogs.
    Tozuka Z; Yazawa H; Murata M; Takaya T
    J Antibiot (Tokyo); 1983 Dec; 36(12):1699-708. PubMed ID: 6662811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antitumor substance BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity.
    Kojiri K; Kondo H; Yoshinari T; Arakawa H; Nakajima S; Satoh F; Kawamura K; Okura A; Suda H; Okanishi M
    J Antibiot (Tokyo); 1991 Jul; 44(7):723-8. PubMed ID: 1652582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia.
    Takahashi I; Yorimitsu S; Hara M; Inagaki T; Nakada H; Sekito N; Hayashi N; Nonaka K; Ohmoto E; Uchida K
    Acta Med Okayama; 1986 Jun; 40(3):175-7. PubMed ID: 3461685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of steffimycin B.
    Wiley PF; Elrod DW; Harper DE
    J Antibiot (Tokyo); 1988 Mar; 41(3):343-51. PubMed ID: 3366692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of a new antitumor antibiotic, sporamycin.
    Komiyama K; Takeshima H; Umezawa I
    Gan; 1977 Apr; 68(2):213-9. PubMed ID: 892295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
    Fujimoto S; Inagaki J; Horikoshi N; Ogawa M
    Gan; 1979 Aug; 70(4):411-20. PubMed ID: 92432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potent anthracyclines, barminomycins I and II.
    Uchida T; Imoto M; Takahashi Y; Odagawa A; Sawa T; Tatsuta K; Naganawa H; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1988 Mar; 41(3):404-8. PubMed ID: 3163334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.